NEW YORK ( TheStreet) -- Complete Genomics (Nasdaq: GNOM) hit a new 52-week low Wednesday as it is currently trading at $2.15, below its previous 52-week low of $2.21 with 211,067 shares traded as of 10:10 a.m. ET. Average volume has been 1.9 million shares over the past 30 days. Complete Genomics has a market cap of $90.8 million and is part of the health care sector and drugs industry. Shares are down 23.5% year to date as of the close of trading on Tuesday. Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter